Patents by Inventor Beat Fluehmann

Beat Fluehmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080307907
    Abstract: A method for predicting (a) the seriousness of side effects to be expected in humans after consumption of foods or nutritional supplements containing oils rich in polyunsaturated fatty acids and/or (b) the acceptance of such foods or nutritional supplements by consumers, characterized by analyzing the foods or nutritional supplements with automated solid phase micro extraction (SPME) followed by ammonia negative chemical ionization mass spectrometric detection.
    Type: Application
    Filed: December 15, 2006
    Publication date: December 18, 2008
    Inventor: Beat Fluehmann
  • Patent number: 7179842
    Abstract: The present invention is a method for the treatment or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired glucose tolerance such as obesity, and in particular to the use of phytanic acid derivatives for the said treatment and/or prevention. A method of making a composition for the treatment or prevention of non-insulin dependent diabetes mellitus and related diseases comprising combining phytanic acid or derivatives thereof with a pharmaceutically acceptable additive or adjuvant, and a composition for the treatment or prevention of non-insulin dependent diabetes mellitus comprising phytanic acid or derivatives thereof are also provided.
    Type: Grant
    Filed: January 27, 2004
    Date of Patent: February 20, 2007
    Assignee: DSm Nutritional Products, Inc.
    Inventors: Beat Fluehmann, Manuel Heim, Willi Hunziker, Peter Weber
  • Patent number: 6784207
    Abstract: The present invention is a method for the treatment or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired glucose tolerance such as obesity, and in particular to the use of phytanic acid derivatives for the said treatment and/or prevention. A method of making a composition for the treatment or prevention of non-insulin dependent diabetes mellitus and related diseases comprising combining phytanic acid or derivatives thereof with a pharmaceutically acceptable additive or adjuvant, and a composition for the treatment or prevention of non-insulin dependent diabetes mellitus comprising phytanic acid or derivatives thereof are also provided.
    Type: Grant
    Filed: July 25, 2001
    Date of Patent: August 31, 2004
    Assignee: Roche Vitamins Inc.
    Inventors: Beat Fluehmann, Willi Hunziker
  • Publication number: 20040138181
    Abstract: The present invention is a method for the treatment or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired glucose tolerance such as obesity, and in particular to the use of phytanic acid derivatives for the said treatment and/or prevention. A method of making a composition for the treatment or prevention of non-insulin dependent diabetes mellitus and related diseases comprising combining phytanic acid or derivatives thereof with a pharmaceutically acceptable additive or adjuvant, and a composition for the treatment or prevention of non-insulin dependent diabetes mellitus comprising phytanic acid or derivatives thereof are also provided.
    Type: Application
    Filed: January 27, 2004
    Publication date: July 15, 2004
    Applicant: ROCHE VITAMINS INC.
    Inventors: Beat Fluehmann, Manuel Heim, Willi Hunziker, Peter Weber
  • Publication number: 20020082298
    Abstract: The present invention is a method for the treatment or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired glucose tolerance such as obesity, and in particular to the use of phytanic acid derivatives for the said treatment and/or prevention. A method of making a composition for the treatment or prevention of non-insulin dependent diabetes mellitus and related diseases comprising combining phytanic acid or derivatives thereof with a pharmaceutically acceptable additive or adjuvant, and a composition for the treatment or prevention of non-insulin dependent diabetes mellitus comprising phytanic acid or derivatives thereof are also provided.
    Type: Application
    Filed: July 25, 2001
    Publication date: June 27, 2002
    Applicant: F. Hoffmann-La Roche AG
    Inventors: Beat Fluehmann, Manuel Heim, Willi Hunziker, Peter Weber